Effect of lamivudine treatment in patients with decompensated cirrhosis due to anti-HBe positive/HBeAg-negative chronic hepatitis B-Reference-Cited by-同舟云学术

Effect of lamivudine treatment in patients with decompensated cirrhosis due to anti-HBe positive/HBeAg-negative chronic hepatitis B

Published:2005-06 Issue:3 Volume:19 Page:321-326
ISSN:0902-0063
Container-title:Clinical Transplantation
language:en
Short-container-title:Clin Transplant

Author:

Nikolaidis Nikolaos,Vassiliadis Themistoklis,Giouleme Olga,Tziomalos Konstantinos,Grammatikos Nikolaos,Patsiaoura Kalliopi,Orfanou-Koumerkeridou Eleni,Balaska Aikaterini,Eugenidis Nikolaos

Publisher

Wiley

Subject

Transplantation

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1399-0012.2005.00340.x/fullpdf

Reference36 articles.

1. Survival and prognostic indicators in hepatitis B surface antigen-positive cirrhosis of the liver

2. Prophylaxis against hepatitis B recurrence following liver transplantation using combination lamivudine and hepatitis B immune globulin

3. Treatment of decompensated viral hepatitis B-induced cirrhosis with low doses of interferon alpha

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Baveno VII concept of cirrhosis recompensation;Digestive and Liver Disease;2023-04

2. Delisting of liver transplant candidates following recompensation of chronic liver diseases – patient characteristics and predictors of delisting: a prospective study;Russian Journal of Transplantology and Artificial Organs;2020-02-02

3. Characteristics of liver transplant candidates delisted following recompensation and predictors of such delisting in alcohol-related liver disease: a case-control study;Transplant International;2017-07-27

4. Meta-analysis: oral anti-viral agents in adults with decompensated hepatitis B virus cirrhosis;Alimentary Pharmacology & Therapeutics;2012-01-19

5. Current Nucleos(t)ide Analogue Therapy for Chronic Hepatitis B;Gut and Liver;2011-09-30